European Heart Journal Advance Access published online on December 19, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi696
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Academic Department of Cardiology, Castle Hill Hospital, University of Hull, Castle Road, Cottingham, Hull HU16 5JQ, UK
* To whom correspondence should be addressed. Aims To determine the prevalence and incidence of renal dysfunction (RD) in patients with chronic heart failure (CHF), to identify contributory factors and predictors of worsening renal function (WRF), and to explore the relationship between RD and mortality. Methods and results Prospective data on 1216 patients with CHF were analysed. The glomerular filtration rate (GFR) was used to determine renal function, and WRF was defined as an increase in serum creatinine of > 26.5 µmol/L (>0.3 mg/dL). The prevalence of RD defined as a GFR of < 60 mL/min was 57%. During 6 months, WRF occurred in 161 (13.0%) patients. Predictors of WRF were vascular disease, the use of thiazide diuretics, and a baseline urea > 9 mmol/L. Two hundred and sixty-three (21.6%) patients died, and baseline RD and WRF both predicted a higher mortality (P < 0.001), whereas an improvement in renal function over the first 6 months predicted a lower mortality (hazard ratio 0.8, 95% confidence interval 0.6-1.0). Conclusion In ambulatory patients with CHF, RD is common, commonly deteriorates over a relatively short period of time, is unlikely to recover substantially, and augurs a poor prognosis.
Received January 31, 2005
Revised November 6, 2005
Accepted December 1, 2005
Clinical research
Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis
Ramesh de Silva 1 *,
Nikolay P. Nikitin 1,
Klaus K.A. Witte 1,
Alan S. Rigby 1,
Kevin Goode 1,
Sunil Bhandari 2,
Andrew L. Clark 1,
and
John G.F. Cleland 1
2 Department of Nephrology, Hull and East Yorkshire NHS Trust, Hull, UK
Ramesh de Silva, E-mail: ramesh{at}desilva84.freeserve.co.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Klein, B. M. Massie, J. D. Leimberger, C. M. O'Connor, I. L. Pina, K. F. Adams Jr, R. M. Califf, M. Gheorghiade, and for the OPTIME-CHF Investigators Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) CIRCULATION: HEART FAILURE, May 1, 2008; 1(1): 25 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Amsalem, M. Garty, R. Schwartz, A. Sandach, S. Behar, A. Caspi, S. Gottlieb, D. Ezra, B. S. Lewis, and J. Leor Prevalence and significance of unrecognized renal insufficiency in patients with heart failure Eur. Heart J., April 2, 2008; 29(8): 1029 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kazory and E. A. Ross Contemporary Trends in the Pharmacological and Extracorporeal Management of Heart Failure: A Nephrologic Perspective Circulation, February 19, 2008; 117(7): 975 - 983. [Abstract] [Full Text] [PDF] |
||||


